Serum Collection Study for Assay Development
NCT07205289 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2025-10-03
Summary
The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation
Conditions
- Pneumococcal Disease, Invasive
- Pneumococcal Disease
Interventions
- BIOLOGICAL
-
Gamma-PN
Killed whole-cell pneumococcal vaccine
Sponsors & Collaborators
-
GPN Vaccines
lead INDUSTRY
Principal Investigators
-
Eve Kennedy, PhD · GPN Vaccines Ltd
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 69 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-10-31
- Primary Completion
- 2026-01-31
- Completion
- 2026-06-30
Countries
- Australia
Study Locations
More Related Trials
-
7-valent Pneumococcal Conjugated Vaccination
NCT00885625 ·Status: UNKNOWN ·Phase: PHASE4
-
Study Evaluating 7-Valent Pneumococcal Conjugate Vaccine in Healthy Infants
NCT00488826 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
NCT05452941 ·Status: RECRUITING
-
Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection
NCT00371878 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of Age
NCT03313050 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Safety of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Elderly Subjects
NCT00500266 ·Status: COMPLETED ·Phase: PHASE3
-
Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines
NCT07135453 ·Status: RECRUITING ·Phase: PHASE4
-
Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™
NCT00772928 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine
NCT05540028 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants
NCT06790290 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study Evaluating Persistence Of Antibody Response Elicited By 13vPnC In Healthy Adults Previously Vaccinated
NCT01025336 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Understand the Safety of the 20vPnC Vaccine in Healthy Chinese Adults, Children, and Infant
NCT07023081 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Clinical Trial of Recombinant Pneumococcal Protein Vaccine
NCT05622942 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn About How Well the Prevnar 20 Vaccine Works for Pneumonia in People Who Are 65 Years and Older
NCT06782282 ·Status: ACTIVE_NOT_RECRUITING
-
A Phase I Clinical Study to Evaluate the Safety of PCV26 in Individuals ≥60
NCT06970756 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Learn About the Safety and Immune Response of 20vPnC in Adults in India.
NCT05875727 ·Status: COMPLETED ·Phase: PHASE3
-
Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults
NCT01444352 ·Status: COMPLETED ·Phase: PHASE1
-
Pneumococcal Reference Standard
NCT00479323 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine
NCT00521586 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults
NCT02892812 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniae
NCT02116998 ·Status: COMPLETED ·Phase: PHASE2
-
Recombinant Attenuated Salmonella Typhi Vaccine Vectors Producing Streptococcus Pneumoniae PspA
NCT01033409 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn About How a New Pneumococcal Vaccine Works in Adults
NCT07086677 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
PhaseⅠClinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine
NCT07025876 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine With Influenza Vaccine in Adults
NCT00492557 ·Status: COMPLETED ·Phase: PHASE3